Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Kuleon LLC has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 3 distinct examiners across 2 distinct art units, indicating that the portfolio spans more examiner assignments than technical groups.
WILLIS, DOUGLAS M is the busiest examiner, with 1 pending matter. No examiner holds more than that recorded amount, so prosecution attention is distributed rather than centered on one examiner. Counsel may benefit from coordinating responses by art unit while preserving examiner-specific claim and argument strategies.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 2 (67%) |
| §112 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.8% |
| SHAMEEM, GOLAM M | 1 | 86.8% | +15.8% |
| YOO, SUN JAE | 1 | 70.9% | +1.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18717142 | Polypodal Serotonergic Compounds and Prodrugs of Serotonin Receptors Agonists and Antagonists | WILLIS, DOUGLAS M | — |
| 18716589 | Serotonin Receptor Agonists and Methods of Making and Using the Same | SHAMEEM, GOLAM M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18717142 | Polypodal Serotonergic Compounds and Prodrugs of Serotonin Receptors Agonists and Antagonists | WILLIS, DOUGLAS M | — |
| 18716589 | Serotonin Receptor Agonists and Methods of Making and Using the Same | SHAMEEM, GOLAM M | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18717142 | Polypodal Serotonergic Compounds and Prodrugs of Serotonin Receptors Agonists and Antagonists | WILLIS, DOUGLAS M | 1624 | §112 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18716589 | Serotonin Receptor Agonists and Methods of Making and Using the Same | SHAMEEM, GOLAM M | 1621 | §102 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18614982 | Serotonin Receptor Agonists and Methods of Making and Using the Same | YOO, SUN JAE | 1621 | §102 | Non-Final OA | — | Pending | Mar 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKuleon LLC has 3 pending office actions as of November 2026, spread across 2 art units and 3 examiners.
Douglas M Willis has the most, with 1 of Kuleon LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.